Ambu A/S (OTCMKTS:AMBBY) Hits New 1-Year Low – Should You Sell?

Ambu A/S (OTCMKTS:AMBBYGet Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.35 and last traded at $15.24, with a volume of 1500 shares trading hands. The stock had previously closed at $15.63.

Ambu A/S Price Performance

The company has a market capitalization of $3.58 billion and a PE ratio of 126.96. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.09. The company’s 50 day moving average price is $17.24 and its 200-day moving average price is $18.84.

Ambu A/S Dividend Announcement

The company also recently declared a dividend, which will be paid on Monday, December 23rd. Stockholders of record on Friday, December 6th will be paid a dividend of $0.0557 per share. The ex-dividend date is Friday, December 6th. Ambu A/S’s dividend payout ratio (DPR) is presently 25.00%.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Further Reading

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.